波兰儿童强制接种PCV10对侵袭性肺炎球菌疾病的直接影响
本研究评估2017年波兰国家免疫规划引入PCV10对5岁以下儿童侵袭性肺炎球菌疾病(IPD)菌株血清型分布和抗菌药物敏感性的直接影响。结果显示,PCV10血清型所致IPD比例从52.1%降至8.1%,耐药肺炎球菌中PCV10血清型从65.4%降至9.8%;后期非PCV10血清型19A(37.6%)和3型(17.9%)最常见,19A占所有多重耐药(MDR)病例的77.0%。结论支持波兰国家免疫规划引入含19A多糖的疫苗并强调持续IPD监测的重要性。
要点
- PCV10血清型所致IPD比例从52.1%降至8.1%,耐药肺炎球菌中PCV10血清型从65.4%降至9.8%。
- 后期非PCV10血清型19A(37.6%)和3型(17.9%)最常见,19A占MDR病例的77.0%。
- 作者认为研究结果支持波兰国家免疫规划引入含19A多糖的疫苗,并强调持续IPD监测的重要性。
核心结论
- 波兰国家免疫规划引入PCV10显著减少了PCV10血清型所致感染,包括与耐药肺炎球菌相关的感染。
- 同时非PCV10血清型流行率增加,尤其是血清型19A,目前占全部感染的三分之一。
- 作者认为研究结果支持波兰国家免疫规划引入含19A多糖的疫苗,并强调持续IPD监测的重要性。
研究设计与样本
- 研究纳入2013年7月至2023年6月期间提交至参考中心的波兰5岁以下儿童IPD所有肺炎球菌菌株。
- 研究定义四个分析期:PCV10前(2013年7月-2016年6月)、PCV10早期后(2017年7月-2020年6月)、COVID-19大流行期(2020年7月-2021年6月)和PCV10后期后(2021年7月-2023年6月)。
- 采用常规技术进行菌株鉴定、血清分型和抗菌药物敏感性试验。
主要发现
- 引入PCV10后,5岁以下儿童中PCV10血清型所致IPD病例比例从52.1%显著下降至8.1%。
- 耐药肺炎球菌中PCV10血清型比例显著下降,包括MDR分离株从65.4%降至9.8%。
- PCV10后期后,血清型19A(37.6%)和血清型3(17.9%)是最常见的分离株。
- PCV10后期后,19A肺炎球菌占所有MDR病例的77.0%。
临床怎么用
- 作者认为研究结果支持波兰国家免疫规划引入含19A多糖的疫苗。
- 作者强调持续IPD监测的重要性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The introduction of pneumococcal conjugate vaccines (PCVs) into National Immunization Programs (NIP) has led to a significant decrease in pneumococcal infections. This study aimed to evaluate the direct impact of the introduction of PCV10 into the NIP in 2017 on the serotype distribution and antimicrobial susceptibility of pneumococci causing invasive pneumococcal disease (IPD) in Polish children. METHODS: The study encompassed all pneumococcal strains responsible for IPD in Polish children under five years of age submitted to the reference centre between July 2013 and June 2023. Four analysis periods were defined: pre-PCV10 (July 2013-June 2016), early post-PCV10 (July 2017-June 2020), COVID-19 pandemic (July 2020-June 2021), and late post-PCV10 (July 2021-June 2023). Routine techniques were utilized for identification, serotyping, and antimicrobial susceptibility testing. RESULTS: Following the introduction of PCV10, a significant decline in the proportion of IPD cases caused by PCV10 serotypes in children under five years of age was observed, decreasing from 52.1 % to 8.1 %. Also significant was a decrease of PCV10 serotypes among resistant pneumococci, including MDR isolates which dropped from 65.4 % to 9.8 %. In the late post-PCV10 period, isolates of serotype 19A (37.6 %) and serotype 3 (17.9 %) were the most prevalent. In the late post-PCV10 period, 19A pneumococci accounted for 77.0 % of all MDR cases. CONCLUSIONS: The introduction of PCV10 into the Polish NIP significantly reduced infections caused by PCV10 serotypes, including infections associated with resistant pneumococci. Concurrently, we noted an increase in the prevalence of non-PCV10 serotypes, notably serotype 19 A, which presently constitutes one-third of the total infections. The results of our study support the need to introduce a vaccine containing 19A polysaccharides into the Polish NIP and emphasizes the importance of continuous IPD surveillance.
引用
- Skoczyńska A, Gołębiewska A, Wróbel-Pawelczyk I, et al. The direct impact of mandatory PCV10 vaccination on invasive pneumococcal disease in Polish children. Vaccine. 2025. PMID: 40081231. doi:10.1016/j.vaccine.2025.126999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。